Performance evaluation of QuantiBRITE phycoerythrin beads.
about
Quantitative characterization of cellular membrane-receptor heterogeneity through statistical and computational modelingMultiplexed microbead immunoassays by flow cytometry for molecular profiling: Basic concepts and proteomics applications.Neutrophil migration towards C5a and CXCL8 is prevented by non-steroidal anti-inflammatory drugs via inhibition of different pathwaysVisual inspection versus quantitative flow cytometry to detect aberrant CD2 expression in malignant T cellsVariables in the quantification of CD4 in normals and hairy cell leukemia patients.Expression of VEGF receptors on endothelial cells in mouse skeletal muscle.Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.Flow Cytometry as a Tool for Quality Control of Fluorescent Conjugates Used in ImmunoassaysImmunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.The Early Expression of HLA-DR and CD64 Myeloid Markers Is Specifically Compartmentalized in the Blood and Lungs of Patients with Septic Shock.Cross-arm binding efficiency of an EGFR x c-Met bispecific antibody.Optimized flow cytometry protocol for analysis of surface expression of interleukin-1 receptor types I and II.Quantitative fluorescent profiling of VEGFRs reveals tumor cell and endothelial cell heterogeneity in breast cancer xenografts.Impact of Cell-surface Antigen Expression on Target Engagement and Function of an Epidermal Growth Factor Receptor × c-MET Bispecific Antibody.qFlow Cytometry-Based Receptoromic Screening: A High-Throughput Quantification Approach Informing Biomarker Selection and Nanosensor Development.Quantification of cell surface proteins with bispecific antibodies.Inter-individual differences in HLA expression can impact the CDC crossmatch.Quantification and cell-to-cell variation of vascular endothelial growth factor receptors.VEGFR1 promotes cell migration and proliferation through PLCγ and PI3K pathways.Role for ZAP-70 Signaling in the Differential Effector Functions of Rituximab and Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia B Cells.A Quantitative Method for Comparing the Brightness of Antibody-dye Reagents and Estimating Antibodies Bound per Cell.Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus.
P2860
Q28538791-51F033F5-4645-453C-8E5E-5DDBFB69D6D8Q33465218-3B6A2D94-2AD2-4011-8D13-D06FB26D733AQ33929754-FC626BDB-D75F-408A-883C-458680360A96Q34044600-237CD074-142B-49BB-91C7-5B728CFCD46CQ34292851-66143379-D82D-477F-9367-8C17965F367AQ34416113-3FB601ED-9D3E-42E3-9540-565FFED976AAQ35558962-093F2B8F-3A24-47B2-A874-85298B45EA24Q36217912-EABC6BDE-B947-4D6B-8FAF-2B7596011550Q36921315-8BA34B22-C19E-4E3E-BFC1-9E4197C28611Q37060070-E342BE9E-B7D0-4002-954A-C9784B90AE8CQ37287006-CE90A621-5619-4BA2-8BA2-3DDE28432623Q37668258-5BC31F0B-449D-4991-9079-FEDCF4580650Q37703365-1A983EEA-9D1B-4E3B-84EA-2B831539CDECQ38844694-4840AD8E-34C3-4B61-A00B-608122EB3C82Q38941700-51E215A8-4D62-4202-93E1-7DF93C968036Q39107862-C84284A7-E542-413D-B9A7-618E05E49947Q41197451-25332EE1-8E7C-41E6-A8FE-348D554AA25BQ41791347-690B52F1-860C-467E-9079-915648EF9E46Q47100851-F95B7389-97D5-44B9-B64A-CC02B6BF0FB5Q50889845-3A2D8EB2-EFCA-48E2-B30F-C626974E7A46Q51272897-B703EE94-F7DB-4C59-9AC8-06ADFBCB165BQ55510540-D1DEEBC2-ECAA-40CC-A60B-65F5418773B1
P2860
Performance evaluation of QuantiBRITE phycoerythrin beads.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Performance evaluation of QuantiBRITE phycoerythrin beads.
@en
Performance evaluation of QuantiBRITE phycoerythrin beads.
@nl
type
label
Performance evaluation of QuantiBRITE phycoerythrin beads.
@en
Performance evaluation of QuantiBRITE phycoerythrin beads.
@nl
prefLabel
Performance evaluation of QuantiBRITE phycoerythrin beads.
@en
Performance evaluation of QuantiBRITE phycoerythrin beads.
@nl
P2093
P2860
P1433
P1476
Performance evaluation of QuantiBRITE phycoerythrin beads.
@en
P2093
P2860
P304
P356
10.1002/1097-0320(20011201)45:4<250::AID-CYTO10021>3.0.CO;2-T
P577
2001-12-01T00:00:00Z